Latest News & Updates

Breaking News

  • 1 day ago

  • Simantini Singh Deo

Agios’ PYRUKYND® (mitapivat) Receives Positive CHMP Opinion For Treatment Of Adults With Thalassemia
Breaking News
Kiniksa Pharmaceuticals Receives U.S. Orphan Drug Designation For KPL-387 To Treat Pericarditis

Simantini Singh Deo

Prelude Therapeutics Welcomes Katina Dorton, J.D., MBA, To Its Board of Directors

Simantini Singh Deo

Achieve Life Sciences Secures FDA Commissioner’s Priority Voucher For Cytisinicline To Support Nicotine Cessation In Vaping And E-Cigarette Users

Simantini Singh Deo

Novartis Kisqali® Shows Significant 28% Reduction In Early Breast Cancer Recurrence Risk In 5-Year NATALEE Study

Simantini Singh Deo

Other trending news you may like to read

Agios’ PYRUKYND® (mitapivat) Receives Positive CHMP Opinion For Treatment Of Adults With Thalassemia

CHMP gives positive opinion for Agios’ PYRUKYND to treat alpha- and beta-thalassemia in adults.

Simantini Singh Deo

Pharma Now

Kiniksa Pharmaceuticals Receives U.S. Orphan Drug Designation For KPL-387 To Treat Pericarditis

FDA grants Orphan Drug Designation to Kiniksa’s KPL-387 for treating pericarditis, supporting rare disease innovation.

Simantini Singh Deo

Pharma Now

Prelude Therapeutics Welcomes Katina Dorton, J.D., MBA, To Its Board of Directors

Prelude Therapeutics appoints Katina Dorton to its Board, enhancing precision oncology leadership and strategic expertise.

Simantini Singh Deo

Pharma Now

Achieve Life Sciences Secures FDA Commissioner’s Priority Voucher For Cytisinicline To Support Nicotine Cessation In Vaping And E-Cigarette Users

Achieve Life Sciences receives FDA priority voucher for cytisinicline, advancing first e-cigarette cessation therapy.

Simantini Singh Deo

Pharma Now